<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Engagement of the membrane program <z:hpo ids='HP_0011420'>death</z:hpo>-1 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1) receptor by its ligands suppresses T cell proliferation and cytokine production </plain></SENT>
<SENT sid="1" pm="."><plain>Aberrant over-expression of costimulatory molecules, including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1, has been associated with persistent activation of self-reactive T cells in <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the mechanism underlying the dysfunction of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in the regulation of T-cell activation in such diseases remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we report the overexpression of CD4(+) and CD8(+) T cell <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 and elevated serum levels of soluble <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) patients </plain></SENT>
<SENT sid="4" pm="."><plain>Detailed characterization of soluble <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 revealed that it corresponded to an alternative splice variant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1Deltaex3, which lacks the transmembrane domain but has a soluble extracellular domain of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 molecule </plain></SENT>
<SENT sid="5" pm="."><plain>In a further study, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 fusion protein displayed the ability of increasing the proliferation of T cells in vitro, which suggested that soluble <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 might serve as an autoimmune antibody to block the function of membrane-bound <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 on T cells and lead to aberrant T cell proliferation </plain></SENT>
<SENT sid="6" pm="."><plain>Our study revealed a novel pathogenic pathway in which the function of overexpressed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 to restrict over-self-reaction is counteracted by the excessive production of soluble <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 </plain></SENT>
</text></document>